Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Compensated Liver Cirrhosis”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT02143778
What this trial is testing

Assessing Portal Hypertension With Methacetin Breath Test

Who this might be right for
Patients With Compensated Liver Cirrhosis
Meridian Bioscience, Inc. 246
Not applicableStudy completedNCT03342170
What this trial is testing

Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?

Who this might be right for
Alcoholic or Viral C Compensated Cirrhosis
University Hospital, Caen 1,500
Testing effectiveness (Phase 2)UnknownNCT03067883
What this trial is testing

Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis Patients

Who this might be right for
Chronic Hepatitis c
Ain Shams University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222
What this trial is testing

Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Who this might be right for
NASHCirrhosis, Liver
Madrigal Pharmaceuticals, Inc. 845
Not applicableUnknownNCT06397859
What this trial is testing

Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis

Who this might be right for
Hepatitis D
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 266
Large-scale testing (Phase 3)UnknownNCT02732405
What this trial is testing

Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis

Who this might be right for
Hepatitis CCompensated Cirrhosis
Istituto Clinico Humanitas 120
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07663643
What this trial is testing

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 459
Testing effectiveness (Phase 2)Study completedNCT01749150
What this trial is testing

Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 61
Not applicableLooking for participantsNCT07469319
What this trial is testing

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Cirrhosis
University of Aarhus 617
Early research (Phase 1)Study completedNCT01454336
What this trial is testing

Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone

Who this might be right for
Liver Fibrosis
Royan Institute 3
Testing effectiveness (Phase 2)Study completedNCT06267794
What this trial is testing

Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.

Who this might be right for
Liver FibrosisCirrhosis, LiverChronic Liver Disease
Jorge L Poo 180
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Not applicableUnknownNCT06147947
What this trial is testing

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD

Who this might be right for
Liver CirrhosisLiver FibrosisPortal Hypertension
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableStudy completedNCT03053180
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Who this might be right for
Chronic Hepatitis C
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT01640964
What this trial is testing

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

Who this might be right for
Compensated Cirrhosis and Portal Hypertension
Novartis Pharmaceuticals 47
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Looking for participantsNCT05749822
What this trial is testing

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases 104
Large-scale testing (Phase 3)Study completedNCT00048724
What this trial is testing

Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)

Who this might be right for
Chronic Hepatitis CCirrhosis
Merck Sharp & Dohme LLC 631
Next Page